Report Materials
Our objective was to determine whether the Commonwealth of Virginia complied with the CMS 'Reimbursement of State Costs for Provision of Part D Drugs' demonstration project requirements related to reimbursed drug claims for full benefit dual eligible beneficiaries. Virginia complied with CMS's demonstration project requirements related to reimbursed drug claims for dual eligible beneficiaries. We are not submitting recommendations to Virginia.
Notice
This report may be subject to section 5274 of the National Defense Authorization Act Fiscal Year 2023, 117 Pub. L. 263.